Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2026-01-24 @ 11:58 PM
Study NCT ID:
NCT00911261
Status:
COMPLETED
Last Update Posted:
2010-02-15
First Post:
2009-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
Sponsor:
Endo Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EN3202-029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Sr. Director, CR&D
Old Organization:
Endo Pharmaceuticals Inc.